Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden

Autor: Raul Allan Kiivet, Ly Rootslane, Adrián LLerena, T. Eklundh, J. Sanchez Vega, ML Dahl, F. Sjoqvist

Publikováno v: British journal of clinical pharmacology. 40(5)

1. Patterns of drug treatment and the use of polypharmacy in schizophrenic in-patients were compared and evaluated in the University Teaching Hospitals of Psychiatry in Badajoz, Spain, Huddinge, Sweden, and Tartu, Estonia. 2. The medical records of u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8733c5c3145c5a94b86bd3aa6db7105
https://pubmed.ncbi.nlm.nih.gov/8703651

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway

Autor: Schwieler L, Markus Larsson, Skogh E, Me, Kegel, Orhan F, Abdelmoaty S, Finn A, Bhat M, Samuelsson M, Lundberg K, Ml, Dahl, Sellgren C, Schuppe-Koistinen I, Svensson C, Erhardt S, Engberg G

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::32fd8315f208a5fab28bf9bdd3d85281
http://europepmc.org/abstract/med/25455350

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes

Autor: Griskevicius L, Yasar U, Sandberg M, Hidestrand M, Eliasson E, Tybring G, Moustapha Hassan, Ml, Dahl

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bbc17a9f8799899aa4f3f99e8ca8703c
http://europepmc.org/abstract/med/12684728

Lived experiences of closeness to a person using Anabolic androgenic steroids a next of kin perspective.

Autor: Börjesson A; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Ekebergh M; Faculty of Caring Science, Worklife and Social Welfare, University of Borås, Borås, Sweden., Dahl ML; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Ekström L; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Lehtihet M; Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Vicente V; The ambulance medical service in Stockholm (AISAB), Academic EMS Stockholm and Department of Clinical Science and Education, Södersjukhuset Karolinska Institutet, Stockholm, Sweden.

Publikováno v: International journal of qualitative studies on health and well-being [Int J Qual Stud Health Well-being] 2024 Dec; Vol. 19 (1), pp. 2292826. Date of Electronic Publication: 2023 Dec 12.

Sub- and supratherapeutic efavirenz plasma concentrations with risk for HIV therapy failure are mainly genetically explained in Ugandan children: The prospective GENEFA cohort study.

Autor: Soeria-Atmadja S; Department of Clinical Science, Intervention and Technology, Division of Paediatrics, Karolinska Institutet, Stockholm, Sweden.; Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden., Amuge P; Baylor College of Medicine, Children's Foundation-Uganda, Kampala, Uganda., Nanzigu S; Department of Clinical Pharmacology & Therapeutics, Makerere University, Kampala, Uganda., Bbuye D; Baylor College of Medicine, Children's Foundation-Uganda, Kampala, Uganda., Eriksen J; Unit of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm, Sweden.; Department of Public Health, Karolinska Institutet, Stockholm, Sweden., Rubin J; Department of Clinical Science, Intervention and Technology, Division of Paediatrics, Karolinska Institutet, Stockholm, Sweden.; Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden., Kekitiinwa A; Baylor College of Medicine, Children's Foundation-Uganda, Kampala, Uganda., Obua C; Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda., Dahl ML; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden., Pettersson Bergstrand M; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden., Pohanka A; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden., Gustafsson LL; Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden., Navér L; Department of Clinical Science, Intervention and Technology, Division of Paediatrics, Karolinska Institutet, Stockholm, Sweden.; Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.